Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02882282
Brief Title: Study of Pembrolizumab (MK-3475) for High Risk Oral Intra-Epithelial Neoplasias

First Submitted : August 24, 2016
First Submitted that Met QC Criteria : August 24, 2016
First Posted : August 29, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 24, 2019
Last Update Posted : January 28, 2019